Lalwani Nikhil

Lalwani Nikhil is listed in filings as PRESIDENT & CEO at ANI Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity. Recent filings connect the profile to ANI Pharmaceuticals, Inc. (ANIP). The current snapshot covers public activity from Sep 10, 2024 to May 13, 2026. Reported amounts are shown as $220.6K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.